Oral squamous cell carcinoma in young patients
DOI:
https://doi.org/10.35954/SM2021.40.1.4Keywords:
Carcinoma, Squamous Cell; Squamous Cell Carcinoma of Head and Neck; Head and Neck Neoplasms; Mouth Neoplasms; DentistryAbstract
Oral squamous cell carcinoma is the most frequent malignant neoplasm of the oral cavity, occurring mainly in people over 60 years of age, although recently an increase in its incidence has been observed in young individuals.
The etiology of oral squamous cell carcinoma in young patients is still not clarified, and it is highlighted in the literature that classic risk factors such as tobacco, alcohol and infection by the Human Papilloma Virus are not implicated in its etiopathogenesis; being the tumor microenvironment the main biological difference observed between the different age groups.
Historically it was considered that oral squamous cell carcinoma in young people was more aggressive, however, current studies have shown that there are no significant differences with respect to that developed by older people, highlighting that the prognosis and treatment plan should not be defined according to the chronological age at the time of diagnosis, but by the stage of the disease.
In this paper we review the literature with the purpose of updating the knowledge about oral squamous cell carcinoma in young patients, highlighting the importance that every health professional who works in the oral cavity should be aware of it, routinely examining the soft tissues and in case of any lesion suspicious of malignancy, regardless of age and the association or not of risk factors, make the appropriate referral.
Received for review: October 2020.
Accepted for publication: February 2021.
Correspondence: General las Heras 1925. C.P.11600. Montevideo, Uruguay. Tel: (+598) 2487 3048.
Contact e-mail: hnmondon@montevideo.com.uy
Downloads
References
(1) Gamez ME, Kraus R, Hinni ML, Moore EJ, Ma DJ, Ko SJ, et al. Treatment outcomes of squamous cell carcinoma of the oral cavity in young adults. Oral Oncol [Internet]. 2018;87(August):43-48. Available from: https://doi.org/10.1016/j.oraloncology.2018.10.014 [Consulted 15/08/2020]
(2) de Morais EF, Mafra RP, Gonzaga AKG, de Souza DLB, Pinto LP, da Silveira ÉJD. Prognostic Factors of Oral Squamous Cell Carcinoma in Young Patients: A Systematic Review. J Oral Maxillofac Surg [Internet]. 2017;75(7):1555-1566. Available from: http://dx.doi.org/10.1016/j.joms.2016.12.017 [Consulted 15/08/2020]
(3) Villanueva FG, Leyva ER, Gaitan LA. Cáncer en pacientes Jóvenes (Parte 1): Análisis clínico e histopatológico de carcinoma de células escamosas de la cavidad bucal en pacientes jóvenes. Un estudio descriptivo y comparativo en México. Odontoestomatología [Internet]. 2016 Mayo [citado 2020 Ago 14] ; 18(27):44-48. Disponible en: http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S1688-93392016000100006&lng=es.
(4) Santos HB, dos Santos TK, Paz AR, Cavalcanti YW, Nonaka CF, Godoy GP, et al. Clinical findings and risk factors to oral squamous cell carcinoma in young patients: A 12-year retrospective analysis. Med Oral Patol Oral Cir Bucal 2016; 21(2):e151-6. doi: 10.4317/medoral.20770
(5) Nasser H, St. John MA. The promise of immunotherapy in the treatment of young adults with oral tongue cancer. Laryngoscope Investig Otolaryngol 2020;5(2):235-42. doi: 10.1002/lio2.366
(6) Costa V, Kowalski LP, Coutinho-Camillo CM, Begnami MD, Calsavara VF, Neves JI, et al. EGFR amplification and expression in oral squamous cell carcinoma in young adults. Int J Oral Maxillofac Surg 2018; 47(7):817-823. doi: 10.1016/j.ijom.2018.01.002
(7) Jardim JF, Gondak R, Galvis MM, Pinto CA, Kowalski L. A decreased peritumoral CD1a+ cell number predicts a worse prognosis in oral squamous cell carcinoma. Histopathology 2018; 72(6):905-13. doi: 10.1111/his.13415.
(8) Toscano de Brito R, França Perazzo M, Santos Peixoto T, Weege-Nonaka C, de Melo Brito E, Granville-Garcia A. Profile of patients and factors related to the clinical staging of oral squamous cell carcinoma. Rev. salud pública [Internet]. 2018 Apr [cited 2020 Sep 14] ; 20( 2 ): 221-225. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0124-00642018000200221&lng=en. http://dx.doi.org/10.15446/rsap.v20n2.49508.
(9) Yosefof E, Hilly O, Stern S, Bachar G, Shpitzer T, Mizrachi A. Squamous cell carcinoma of the oral tongue: Distinct epidemiological profile disease. Head Neck 2020; 42(9):2316-2320. doi: 10.1002/hed.26177
(10) Komolmalai N, Chuachamsai S, Tantiwipawin S, Dejsuvan S, Buhngamongkol P, Wongvised C, et al. Ten-year analysis of oral cancer focusing on young people in Northern Thailand. J Oral Sci 2015; 57(4):327-34. doi: 10.2334/josnusd.57.327
(11) Oreamuno Y V. Carcinoma oral de células escamosas diagnosticado precozmente: Reporte de caso y revisión de literatura. Odovtos [Internet]. 2017 Apr [citado 2020 Sep 14]; 19( 1 ): 43-50. Disponible en: http://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S2215-34112017000100043&lng=en. http://dx.doi.org/10.15517/ijds.v0i0.28074
(12) Ganesh D, Sreenivasan P, Ohman J, Wallström M, Braz-Silva PH, Giglio D, et al. Potentially malignant oral disorders and cancer transformation. Anticancer Res 2018; 38(6):3223-3229. doi:10.21873/anticanres.12587
(13) Mccormick NJ, Thomson PJ, Carrozzo M. The Clinical Presentation of Oral Potentially Malignant Disorders. Prim Dent J 2016; 5(1):52-63. doi: 10.1177/205016841600500106
(14) Satgunaseelan L, Allanson BM, Asher R, Reddy R, Low HT, Veness M, et al. The incidence of squamous cell carcinoma of the oral tongue is rising in young non-smoking women: An international multi-institutional analysis. Oral Oncol 2020;110:104875. https://doi.org/10.1016/j.oraloncology.2020.104875
(15) Blanchard P, Belkhir F, Temam S, El Khoury C, De Felice F, Casiraghi O, et al. Outcomes and prognostic factors for squamous cell carcinoma of the oral tongue in young adults: a single-institution case-matched analysis. Eur Arch Otorhinolaryngol 2017; 274(3):1683-1690. doi: 10.1007/s00405-016-4419-1
(16) dos Santos Costa SF, Brennan PA, Gomez RS, Fregnani ER, Santos-Silva AR, Martins MD, et al. Molecular basis of oral squamous cell carcinoma in young patients: is it any different from older patients? J Oral Pathol Med 2018; 47(6):541-6. doi: 10.1111/jop.12642
(17) Emerick C, Magalhães TG, Barki MC, Crescencio LR, Tucci R, Barros EM, et al. Perfil sociodemográfico e clinicopatológico de 80 casos de carcinoma de células escamosas de boca. J Bras Patol e Med Lab 2020; 56(1):1-6. https://doi.org/10.5935/1676-2444.20200001
(18) Maroun CA, Zhu G, Fakhry C, Gourin CG, Seiwert TY, Vosler PS, et al. An Immunogenomic Investigation of Oral Cavity Squamous Cell Carcinoma in Patients Aged 45 Years and Younger. Laryngoscope 2020; 1-8. doi: 10.1002/lary.28674
(19) Hanna GJ, Woo SB, Li YY, Barletta JA, Hammerman PS, Lorch JH. Tumor PD-L1 expression is associated with improved survival and lower recurrence risk in young women with oral cavity squamous cell carcinoma. Int J Oral Maxillofac Surg 2018; 47(5):568-577. doi: 10.1016/j.ijom.2017.09.006
(20) Fan Y, Zheng L, Mao MH, Huang MW, Liu SM, Zhang J, et al. Survival analysis of oral squamous cell carcinoma in a subgroup of young patients. Asian Pac J Cancer Prev 2014; 15(20):8887-8891. doi: 10.7314/apjcp.2014.15.20.8887
(21) Mahmood N, Hanif M, Ahmed A, Jamal Q, Saqib M, Khan A. Impact of age at diagnosis on clinicopathological outcomes of oral squamous cell carcinoma patients. Pak J Med Sci 2018; 34(3):595-599. doi: 10.12669/pjms.343.14086
(22) Chandrasekharappa SC, Chinn SB, Donovan FX, Chowdhury NI, Kamat A, Adeyemo AA, et al. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50. Cancer 2017; 123(20):3943-3954. doi: 10.1002/cncr.30802
(23) Pavani N, Srinivas P, Kothia NR, Chandu VC. Recent Advances in the Early Diagnosis of Oral Cancer : A Systematic Review. Int J Medical Rev 2017; 4(4):119-125. doi: 10.29252/IJMR-040406
(24) Netto Soares JR, Dias FL, Monteiro de Araujo Lima RR, Toscano UB, Pastl Pontes AC, Botinelly RD, et al. Assessment of quality of life in patients with advanced oral cancer who underwent mandibulectomy with or without bone reconstruction. Rev Assoc Med Bras 2018; 64(8):710-6. https://doi.org/10.1590/1806-9282.64.08.710
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Hugo Néstor Mondón Alvarez y Natalia Fernanda Tancredi Cueto. The authors retain their copyright and grant the journal the right of first publication of their work, which will be simultaneously subject to the Creative Commons Attribution 4.0 International License that allows sharing the work as long as the initial publication in this journal is indicated.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:
Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.
As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.
Under the following terms:
1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
2. NonCommercial: you may not use the material for commercial purposes.
3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.
PlumX Metrics
/
